# EXECUTIVE DIRECTOR, CLINICAL DEVELOPMENT — Sutro Biopharma

- Location: South San Francisco, CA
- Posted: Oct 23, 2026
- Status: open (checked Nov 20, 2026)
- Apply (employer's site): https://jobs.jobvite.com/sutrobio/job/oBq0Afwl
- Employer record: https://visajobs.io/company/sutro-biopharma.md

## Sponsorship history
- Tier: Employer history only
- Occupation (SOC): General and Operations Managers (11-1021)
- Employer's certified LCAs for this occupation in CA, FY2024–FY2026: 0
- …in the whole US: 0
- With this exact title: 0
- Median DOL prevailing wage, level I / II: $72k / $120k

## Description
EXECUTIVE DIRECTOR, CLINICAL DEVELOPMENT
Position Overview
Sutro Biopharma is seeking an Executive Director, Clinical Development to serve as a thought partner to the VP, Clinical Development in shaping the overarching clinical strategy for its oncology portfolio. Working collaboratively with global study leads, this physician will develop clinical strategies, strengthen safety assessment, and support the execution of global clinical programs. The role is ideally suited for a physician-scientist with deep oncology expertise and prior experience in ADCs or targeted therapies. This role also requires a strong safety background, experience leading clinical studies, and deep knowledge of early development trials, together with the ability to build trusted investigator relationships and translate clinical evidence into clear recommendations.
Key Responsibilities
Clinical strategy and study leadership
Partner with the VP, Clinical Development to evaluate portfolio opportunities, emerging risks, and development options; provide clinical and scientific perspectives that inform overarching strategy and priorities.
Collaborate with global study leads to develop and refine clinical development plans and study strategies, integrating patient populations, dose and schedule, endpoints, biomarkers, geographic considerations, and evidence needed for key decisions.
Apply early development expertise to first-in-human studies, dose escalation, dose optimization, and expansion cohorts; integrate emerging safety, efficacy, pharmacology, and translational data into development recommendations.
Contribute to the design, conduct, interpretation, and communication of clinical studies, including protocols, amendments, investigator materials, and clinical study reports. Partner with study leads and Clinical Operations to address clinical issues and support study milestones.
Clinical safety and medical monitoring
Provide strong clinical safety expertise across programs. Partner with global study leads and Pharmacovigilance to review emerging safety data, assess potential signals and benefit-risk, and recommend appropriate follow-up and risk mitigation.
Serve as a backup medical monitor to global study leads and other designated medical monitors, providing coverage for investigator questions, eligibility assessments, medical review of adverse events, and protocol-related medical decisions.
Support safety review meetings and clinical interpretation of adverse events and laboratory trends; help translate findings into monitoring recommendations, protocol updates, and clear communication to study teams.
Regulatory and leadership communications
Support Regulatory Affairs, the VP, Clinical Development, and study leads in preparing clinical content for regulatory submissions, briefing documents, responses to health authority questions, and regulatory meetings; participate in interactions as appropriate.
Help prepare Board of Directors materials and executive updates, synthesizing clinical progress, safety findings, development options, and key risks into clear, balanced presentations and recommendations.
Investigator engagement and scientific advisory
Build and maintain relationships across the investigator network, academic centers, and external oncology experts. Travel domestically and internationally for site engagement, investigator meetings, scientific congresses, and advisory discussions as needed.
Partner with study leads to gather investigator insights on study design, feasibility, enrollment barriers, and clinical practice, and apply those insights to clinical strategy and study execution.
Help plan and lead scientific advisory boards and expert discussions; develop focused questions, evaluate external input, and translate recommendations into practical development options.
Collaboration and organizational contribution
Work across Clinical Operations, Pharmacovigilance, Translational Medicine, Biostatistics, Data Management, and Regulatory Affairs to align on clinical questions, resolve issues, and support timely decisions.
Mentor colleagues, communicate candidly, and contribute to consistent clinical development practices that support patient safety, scientific rigor, data integrity, and quality.
Qualifications
Required
• MD or MD/PhD required with substantial experience in oncology clinical development.
• Approximately 10 or more years of relevant clinical research and drug development experience, including substantial clinical development experience in the biotechnology or pharmaceutical industry.
• Strong clinical safety background, including medical monitoring, assessment of adverse events and emerging safety signals, benefit-risk evaluation, and collaboration with Pharmacovigilance.
• Prior experience leading interventional clinical studies and direct experience with global trials involving investigators and teams across multiple countries.
• Deep knowledge of early clinical development, including first-in-human studies, dose escalation, dose optimization, and expansion cohorts.
• Ability to partner effectively with senior clinical leaders and global study leads, influence across functions, and translate complex data into sound clinical recommendations.
• Experience contributing to regulatory documents and health authority interactions, with working knowledge of GCP and applicable global clinical trial requirements.
• Strong scientific communication and relationship-building skills, including engagement with investigators and external experts; willingness and ability to travel domestically and internationally.
Preferred
• Board certification or eligibility in medical oncology or hematology/oncology; experience in solid tumors and antibody-drug conjugate development.
• Experience preparing executive or Board-level presentations, supporting scientific advisory boards, and working in a lean biotechnology organization.
Sound exciting? Apply today and join our team!
Sutro Biopharma, Inc. encourages all colleague

> History, not a promise: past H-1B filings do not mean an employer will sponsor you or a given role. Data: U.S. DOL OFLC LCA disclosure (FY2024–FY2026 for role counts, certified LCAs) and the USCIS H-1B Employer Data Hub. Not legal advice. Methodology: https://visajobs.io/methodology
